Golden Throat Holdings Group Co Ltd (6896) AI Stock Analysis

• Market Cap: HK$3.36B
• Dividend Yield: 11.16%
• Average Volume (3M): 915.50K
• Price to Earnings (P/E): 9.7
• Beta (1Y): 0.14
• Revenue Growth: 20.89%
• EPS Growth: 24.98%
• Country: HK
• Employees: 874
• Sector: Healthcare
• Sector Strength: 53
• Industry: Drug Manufacturers - Specialty & Generic
• EPS (TTM): 0.47
• Shares Outstanding: 739,302,000
• 10 Day Avg. Volume: 1,232,200
• 30 Day Avg. Volume: 915,503
• PEG Ratio: 0.45
• Price to Book (P/B): 2.23
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 14.68
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 84 Outperform
• Price Target: ―

Golden Throat Holdings demonstrates a strong overall performance with robust financials, positive technical trends, and attractive valuation metrics. High profitability margins and low leverage underscore its financial health, while the stock's technical momentum and undervaluation enhance its investment appeal. The absence of operating cash flow data for 2024 is a minor concern but is mitigated by historical performance.

Golden Throat Holdings Group Co Ltd Business Overview & Revenue Model

Company Description

Golden Throat Holdings Group Co Ltd (6896) is a leading Chinese company primarily engaged in the production and distribution of throat lozenges. Established in Liuzhou, China, the company has built a strong reputation for its signature product, Golden Throat Lozenge, which is well-known for its soothing and therapeutic properties. The company operates within the pharmaceutical and healthcare sectors, focusing on the development and sale of traditional Chinese medicine products to cater to consumers seeking relief from throat discomfort and related ailments.

How the Company Makes Money

Golden Throat Holdings Group Co Ltd generates revenue primarily through the sale of its flagship product, the Golden Throat Lozenge. The company's revenue model is based on manufacturing and distributing these lozenges across various retail and online channels. Key revenue streams include domestic sales within China and international exports to countries with significant Chinese communities and markets receptive to traditional Chinese medicine. The company leverages its established brand reputation and extensive distribution network to maintain strong sales. Additionally, strategic partnerships with retailers and distributors, along with targeted marketing efforts, contribute to its earnings. The company may also explore product diversification and innovation to expand its market reach and revenue potential.

Golden Throat Holdings Group Co Ltd Financial Statement Overview

Summary

Golden Throat Holdings exhibits strong financial health with impressive revenue growth and profitability margins. The balance sheet is robust, featuring a low debt-to-equity ratio and high return on equity, indicating financial stability. However, the lack of operating cash flow data for 2024 is a concern, though historical cash generation has been strong.

Income Statement

Golden Throat Holdings has demonstrated strong revenue growth, with a 23.3% increase from 2023 to 2024, and maintained robust profitability with a gross profit margin of 75.5% and a net profit margin of 26.9% for 2024. The company's EBIT and EBITDA margins are also solid at 32.8% and 38.5%, respectively, indicating efficient operations and strong earnings before interest and taxes.

Balance Sheet

The company exhibits a healthy balance sheet with a low debt-to-equity ratio of 0.29, highlighting conservative leverage. Additionally, the return on equity is impressive at 21.7%, reflecting efficient use of shareholder funds. The equity ratio of 65.1% further indicates a strong equity base relative to total assets, suggesting financial stability.

Cash Flow

Although the free cash flow in 2024 is not available, the company previously generated positive free cash flow in 2023, which grew by 90.3% from 2022 to 2023. However, the absence of operating cash flow in 2024 is a concern, as it limits the ability to assess current cash generation efficiency relative to net income.

Breakdown
Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement		Total Revenue
1.19B	961.38M	992.01M	820.54M	646.94M
	Gross Profit
894.18M	697.72M	720.92M	577.74M	475.64M
	EBIT
388.73M	349.49M	363.32M	212.95M	138.81M
	EBITDA
456.65M	410.75M	424.93M	281.80M	233.31M
	Net Income Common Stockholders
318.63M	250.16M	281.22M	187.64M	154.05M
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
1.14B	1.07B	925.51M	802.84M	705.54M
	Total Assets
2.25B	2.30B	2.30B	1.95B	1.69B
	Total Debt
426.92M	412.34M	272.59M	235.00M	152.45M
	Net Debt
-703.71M	-619.86M	-622.93M	-487.84M	-553.09M
	Total Liabilities
784.87M	748.34M	760.18M	588.04M	464.75M
	Stockholders Equity
1.47B	1.55B	1.54B	1.37B	1.22B
Cash Flow		Free Cash Flow
0.00	221.30M	255.30M	116.23M	83.80M
	Operating Cash Flow
0.00	238.84M	271.15M	164.89M	167.75M
	Investing Cash Flow
0.00	-59.67M	36.59M	-145.11M	-81.26M
	Financing Cash Flow
0.00	-79.38M	-142.01M	-10.21M	49.36M

Golden Throat Holdings Group Co Ltd Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 4.48
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:6896, the sentiment is Positive. The current price of 4.48 is below the 20-day moving average (MA) of 4.72, above the 50-day MA of 4.30, and above the 200-day MA of 3.25, indicating a neutral trend. The MACD of 0.06 indicates Positive momentum. The RSI at 53.16 is Neutral, neither overbought nor oversold. The STOCH value of 16.58 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:6896.

Golden Throat Holdings Group Co Ltd Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
6896	84 Outperform	HK$3.36B	9.72	21.15%	11.16%	20.89%	24.98%
1112	66 Neutral	$8.26B	21.96	-0.91%	0.78%	-8.10%	-108.48%
3320	62 Neutral	€33.55B	9.23		6.80%	―	―
2319	61 Neutral	$66.29B	587.54	0.21%	3.28%	-11.90%	-97.93%
Sector *	54 Neutral	$5.34B	3.36	-45.10%	3.39%	16.81%	-0.03%
1000	51 Neutral	€138.12M	―	-0.32%	―	2.71%	86.82%

Golden Throat Holdings Group Co Ltd Corporate Events

Golden Throat Holdings Announces Final Dividend for 2024

Golden Throat Holdings Group Co Ltd has announced a final ordinary cash dividend of HKD 0.5 per share for the financial year ending December 31, 2024. The dividend will be paid on June 26, 2025, following shareholder approval on June 3, 2025. This announcement reflects the company’s ongoing commitment to returning value to its shareholders and may impact its financial strategy and stakeholder relations.

Golden Throat Holdings Reports Robust Financial Growth in 2024

Golden Throat Holdings Group Co Ltd announced its annual results for the year ended 31 December 2024, reporting a significant increase in financial performance. The company’s revenue rose by 23.3% to RMB1,185.0 million, and gross profit increased by 28.2% to RMB894.2 million compared to the previous year. The profit attributable to equity holders grew by 27.3% to RMB318.6 million. The Board has recommended a final dividend of HK$0.5 per share, subject to shareholder approval. This financial growth highlights the company’s strong market positioning and potential positive implications for stakeholders.

Golden Throat Holdings Declares Final Dividend for 2024

Golden Throat Holdings Group Co Ltd announced a final cash dividend of HKD 0.5 per share for the financial year ending 31 December 2024, with the payment date set for 26 June 2025. This announcement reflects the company’s stable financial performance and commitment to returning value to its shareholders, potentially strengthening its market position and investor confidence.

Golden Throat Holdings Expects Significant Profit Growth in 2024

Golden Throat Holdings Group Co Ltd has announced a positive profit alert, expecting an increase in operating revenue and profit by approximately 20% to 25% for the year ended December 31, 2024, compared to the previous year. This growth is attributed to a significant rise in annual sales for 2024, although the figures are based on unaudited preliminary assessments and the final results are expected to be published by the end of March 2025.

Golden Throat Holdings Group to Review Annual Results and Dividend Declaration

Golden Throat Holdings Group Co Ltd has announced a board meeting scheduled for March 28, 2025, to discuss and approve the annual financial results for the year ending December 31, 2024. The meeting will also consider the declaration and payment of a final dividend, which could impact the company’s financial strategy and shareholder returns.